{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:52:03Z","timestamp":1790099523028,"version":"4.0.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"\n Background and objective<\/jats:title>\n Portal vein thrombosis (PVT) is a common complication in cirrhosis, and when complete, it increases morbidity and mortality in liver transplant candidates. The aim of the study was to assess the hemostatic status, as well as clinical characteristics of thrombus and patients, as predictors of therapeutic efficacy of anticoagulation for the treatment of PVT in cirrhotics.<\/jats:p>\n <\/jats:sec>\n \n Patients and methods<\/jats:title>\n Patients with cirrhosis consecutively treated for PVT with enoxaparin were enrolled. All patients underwent evaluation of coagulation status and thrombophilia screening. Thrombus characteristics and extension were evaluated at baseline and during follow-up. Anticoagulation was continued until recanalization or up to 12 months. Variables correlated with the response to anticoagulation were used to create a predictive score that was validated in an external multicenter cohort.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 65 patients were included and had partial PVT in most cases (72%). Treatment with enoxaparin resulted in an overall response rate of 66% (43\/65) after a median time of 4.4 months and 76% (33\/43) within the first 6 months. At multivariate analysis, efficacy of anticoagulation correlated with the severity of liver disease, complete verus partial PVT, age of the thrombus, and time interval from treatment start (<6 months). The areas under the curve of the statistical model for predicting the response to anticoagulation were 0.84 and 0.76 for the training (n<\/jats:italic>=65) and validation (n<\/jats:italic>=60) cohorts, respectively.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Early diagnosis and early treatment are key factors for the successful management of PVT in cirrhosis, so that screening of PVT and prompt start of anticoagulant treatment should be mandatory.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/meg.0000000000001237","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T08:53:19Z","timestamp":1536137599000},"page":"34-42","source":"Crossref","is-referenced-by-count":70,"title":["A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis"],"prefix":"10.1097","volume":"31","author":[{"given":"Kryssia I.","family":"Rodriguez-Castro","sequence":"first","affiliation":[{"name":"Surgery, Oncology and Gastroenterology, Multivisceral Transplant Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vitale","sequence":"additional","affiliation":[{"name":"Surgery, Oncology and Gastroenterology, Hepatobiliary Surgery and Liver Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Fadin","sequence":"additional","affiliation":[{"name":"Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Shalaby","sequence":"additional","affiliation":[{"name":"Surgery, Oncology and Gastroenterology, Multivisceral Transplant Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Zerbinati","sequence":"additional","affiliation":[{"name":"Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Sartori","sequence":"additional","affiliation":[{"name":"Clinical Medicine I, Department of Medicine, Padua University Hospital, Padua"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Landi","sequence":"additional","affiliation":[{"name":"Department of Digestive Diseases and Internal Medicine, Division of Internal Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Pettinari","sequence":"additional","affiliation":[{"name":"Department of Digestive Diseases and Internal Medicine, Division of Internal Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Piscaglia","sequence":"additional","affiliation":[{"name":"Department of Digestive Diseases and Internal Medicine, Division of Internal Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohong","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Liver Diseases and Digestive Interventional Radiology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[{"name":"Surgery, Oncology and Gastroenterology, Multivisceral Transplant Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[{"name":"Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[{"name":"Surgery, Oncology and Gastroenterology, Multivisceral Transplant Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00042737-200507000-00009","article-title":"Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors","volume":"17","author":"Mangia","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00042737-200503000-00013","article-title":"Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis","volume":"17","author":"Erkan","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2002-33210","article-title":"Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia","volume":"34","author":"Amitrano","year":"2002","journal-title":"Endoscopy"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano","year":"2004","journal-title":"J Hepatol"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"Yerdel","year":"2000","journal-title":"Transplantation"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hep.1840160515","article-title":"The incidence of portal vein thrombosis at liver transplantation","volume":"16","author":"Nonami","year":"1992","journal-title":"Hepatology"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca","year":"2012","journal-title":"Radiology"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/TP.0b013e31826e8e53","article-title":"Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review","volume":"94","author":"Rodr\u00edguez-Castro","year":"2012","journal-title":"Transplantation"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.4254\/wjh.v7.i27.2774","article-title":"Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: a meta-analysis","volume":"7","author":"Stine","year":"2015","journal-title":"World J Hepatol"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clinre.2015.02.012","article-title":"Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: a systematic review of the literature","volume":"39","author":"Qi","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.dld.2013.08.138","article-title":"Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation","volume":"46","author":"Dell'Era","year":"2014","journal-title":"Dig Liver Dis"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/MEG.0000000000000351","article-title":"Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"27","author":"Cui","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10620-012-2548-y","article-title":"Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation","volume":"58","author":"Werner","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/hep.27225","article-title":"Treating thrombosis in cirrhosis patients with new oral agents: ready or not?","volume":"61","author":"Intagliata","year":"2015","journal-title":"Hepatology"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.26998","article-title":"Treatment of acute portal vein thrombosis by nontraditional anticoagulation","volume":"60","author":"Martinez","year":"2014","journal-title":"Hepatology"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"key":"R23-20230916","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/hepr.12400","article-title":"Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis","volume":"45","author":"Naeshiro","year":"2015","journal-title":"Hepatol Res"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3350\/cmh.2014.20.4.384","article-title":"Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis","volume":"20","author":"Chung","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2013.03.036","article-title":"Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis","volume":"59","author":"Tripodi","year":"2013","journal-title":"J Hepatol"},{"key":"R27-20230916","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1148\/radiology.154.3.3881793","article-title":"Portal thrombosis: dynamic CT features and course","volume":"154","author":"Mathieu","year":"1985","journal-title":"Radiology"},{"key":"R29-20230916","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1148\/radiology.163.2.3031725","article-title":"High-attenuation recent thrombus of the portal vein: CT demonstration and clinical significance","volume":"163","author":"Mori","year":"1987","journal-title":"Radiology"},{"key":"R30-20230916","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2214\/ajr.145.1.73","article-title":"Pulsed Doppler duplex sonography and CT of portal vein thrombosis","volume":"145","author":"Miller","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"R31-20230916","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1055\/s-0037-1616527","article-title":"Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma: characterization of the dysfunctional protein C Padua3 (protein C(R-1L\/propeptide))","volume":"86","author":"Simioni","year":"2001","journal-title":"Thromb Haemost"},{"key":"R32-20230916","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa0904377","article-title":"X-linked thrombophilia with a mutant factor IX (factor IX Padua)","volume":"361","author":"Simioni","year":"2009","journal-title":"N Engl J Med"},{"key":"R33-20230916","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1538-7836.2005.01308.x","article-title":"The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study","volume":"3","author":"Tormene","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R34-20230916","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/107602960000600106","article-title":"Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred","volume":"6","author":"Sartori","year":"2000","journal-title":"Clin Appl Thromb Hemost"},{"key":"R35-20230916","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1111\/j.1538-7836.2007.02727.x","article-title":"The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women: a family study","volume":"5","author":"Tormene","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R36-20230916","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R37-20230916","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"R38-20230916","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00261-011-9795-9","article-title":"Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound","volume":"37","author":"Maruyama","year":"2012","journal-title":"Abdom Imaging"},{"key":"R39-20230916","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2214\/ajr.165.5.7572494","article-title":"Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography","volume":"165","author":"De Gaetano","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"R40-20230916","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"R41-20230916","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1538-7836.2012.04824.x","article-title":"Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis","volume":"10","author":"Senzolo","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R42-20230916","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040161","article-title":"Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children","volume":"351","author":"Goldenberg","year":"2004","journal-title":"N Engl J Med"},{"key":"R43-20230916","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","article-title":"Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial","volume":"67","author":"Lv","year":"2018","journal-title":"Gut"},{"key":"R44-20230916","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejca.2011.12.021","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"48","year":"2012","journal-title":"Eur J Cancer"},{"key":"R45-20230916","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","author":"Chen","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R46-20230916","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cgh.2017.10.016","article-title":"Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis","volume":"16","author":"La Mura","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R47-20230916","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/lt.22105","article-title":"Portal vein thrombosis and liver transplant survival benefit","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl"}],"container-title":["European Journal of Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042737-201901000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T15:29:47Z","timestamp":1694878187000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042737-201901000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000001237","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}